Ticker Launch

SPAC · Merger completed

Tenzing Acquisition Corp.

Business combination with Reviva Pharmaceuticals, Inc.

Tenzing Acquisition Corp. is a blank-check company (SPAC) that raised $55M in its initial public offering on Aug 22, 2018, listing on Nasdaq Capital Market. It completed its business combination with Reviva Pharmaceuticals, Inc. on Dec 14, 2020; the combined company is Reviva Pharmaceuticals Holdings, Inc. (RVPH). Ellenoff Grossman & Schole advised the SPAC and Loeb & Loeb advised the underwriters on the IPO.

Status
Merger completed
IPO date
Aug 22, 2018
IPO size
$55M
IPO exchange
Nasdaq Capital Market
Target
Reviva Pharmaceuticals, Inc.
Announced
Jul 24, 2020
Closed
Dec 14, 2020
Combined company
Reviva Pharmaceuticals Holdings, Inc. (RVPH)
SPAC counsel (IPO)
Ellenoff Grossman & Schole and Ogier
Underwriters' counsel (IPO)
Loeb & Loeb

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2020